Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ILMN – Illumina, Inc.

Illumina, Inc.
ILMN
$120.07
Name : Illumina, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $18,454,759,424.00
EPSttm : 4.46
finviz dynamic chart for ILMN
Illumina, Inc.
$120.07
0.50%
$0.6

Float Short %

4.53

Margin Of Safety %

-14

Put/Call OI Ratio

0.3

EPS Next Q Diff

-0.23

EPS Last/This Y

12.4

EPS This/Next Y

0.28

Price

120.6

Target Price

117.32

Analyst Recom

2.48

Performance Q

20.03

Relative Volume

0.63

Beta

1.45

Ticker: ILMN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20ILMN99.50.180.6481077
2025-10-21ILMN98.980.190.6183425
2025-10-22ILMN97.20.200.8783702
2025-10-23ILMN99.940.200.4583920
2025-10-24ILMN100.110.200.7184204
2025-10-27ILMN100.280.200.3484542
2025-10-28ILMN98.10.200.3886096
2025-10-29ILMN95.020.201.3686448
2025-10-30ILMN99.050.200.7186825
2025-10-31ILMN123.640.240.3195037
2025-11-03ILMN120.020.250.3498978
2025-11-04ILMN116.940.250.67100524
2025-11-05ILMN122.480.250.32100885
2025-11-06ILMN121.10.240.54101126
2025-11-07ILMN121.910.250.72101156
2025-11-10ILMN121.730.241.17101194
2025-11-11ILMN122.680.250.07101860
2025-11-12ILMN121.950.290.5593272
2025-11-13ILMN119.880.290.1793514
2025-11-14ILMN120.730.300.4593297
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20ILMN99.502.8-464.44.50
2025-10-21ILMN99.002.8-507.64.50
2025-10-22ILMN97.232.4-519.04.50
2025-10-23ILMN99.962.4-477.44.50
2025-10-24ILMN100.092.4-501.94.50
2025-10-27ILMN100.342.4-500.94.50
2025-10-28ILMN97.802.4-526.44.50
2025-10-29ILMN95.172.4-527.74.50
2025-10-30ILMN99.012.4-464.84.50
2025-10-31ILMN123.542.4-276.14.50
2025-11-03ILMN120.0243.1-529.94.72
2025-11-04ILMN116.8742.753.44.72
2025-11-05ILMN122.4642.7127.84.72
2025-11-06ILMN121.0942.368.54.71
2025-11-07ILMN121.9042.386.24.71
2025-11-10ILMN121.7242.378.14.71
2025-11-11ILMN122.6042.386.94.71
2025-11-12ILMN121.9642.374.44.71
2025-11-13ILMN119.8942.362.34.71
2025-11-14ILMN120.6042.385.24.71
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20ILMN0.43-0.594.42
2025-10-21ILMN0.43-0.594.42
2025-10-22ILMN0.43-0.594.42
2025-10-23ILMN0.43-0.594.42
2025-10-24ILMN0.43-0.594.42
2025-10-27ILMN0.43-0.594.47
2025-10-28ILMN0.43-0.594.47
2025-10-29ILMN0.43-0.594.47
2025-10-30ILMN0.43-0.594.47
2025-10-31ILMN0.43-0.594.47
2025-11-03ILMN0.43-0.934.47
2025-11-04ILMN0.43-0.934.47
2025-11-05ILMN0.45-0.934.50
2025-11-06ILMN0.45-0.934.50
2025-11-07ILMN0.45-0.934.50
2025-11-10ILMN0.45-1.074.50
2025-11-11ILMN0.45-1.074.50
2025-11-12ILMN0.45-1.074.53
2025-11-13ILMN0.45-1.074.53
2025-11-14ILMN0.45-1.074.53
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.22

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

0.45

Institutional Transactions

-1.07

Beta

1.45

Average Sales Estimate Current Quarter

1103

Average Sales Estimate Next Quarter

1058

Fair Value

104.09

Quality Score

92

Growth Score

40

Sentiment Score

49

Actual DrawDown %

77.7

Max Drawdown 5-Year %

-86.2

Target Price

117.32

P/E

27.03

Forward P/E

24.11

PEG

2.47

P/S

4.3

P/B

7.75

P/Free Cash Flow

18.44

EPS

4.46

Average EPS Est. Cur. Y​

4.71

EPS Next Y. (Est.)

4.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.41

Relative Volume

0.63

Return on Equity vs Sector %

2.6

Return on Equity vs Industry %

18.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.21

EBIT Estimation

85.2
Illumina, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 8970
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading